Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML. (Q44248070)
Jump to navigation
Jump to search
scientific article published on 12 December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML. |
scientific article published on 12 December 2002 |
Statements
1 reference
Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML. (English)
1 reference
Christoph Huber
1 reference
Thomas Kindler
1 reference
Frank Breitenbuecher
1 reference
Andreas Marx
1 reference
Georg Hess
1 reference
Harald Gschaidmeier
1 reference
Heinold Gamm
1 reference
Charles J Kirkpatrick
1 reference
Thomas Fischer
1 reference
12 December 2002
1 reference
Identifiers
1 reference